Salmonellosis atípica. Cuándo sospechar y cómo diagnosticar. En: VII Congreso Regional SEMES Extremadura. Badajoz, 18 y 19 de noviembre de 2016
High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studies.Pharmacogenomics J. 2016 Oct;16(5):485-90.F.I.: 3.784
Genetic variability of CYP2C9*2 and CYP2C9*3 in seven indigenous groups from Mexico.Pharmacogenomics. 2016 Oct 28. [Epub ahead of print]. F.I.:2.701
Allele and genotype frequencies of genes relevant to anti-epileptic drug therapy in Mexican-Mestizo healthy volunteers.Pharmacogenomics. 2016 Oct 28. [Epub ahead of print]. F.I.: 2.701
Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America. Pharmacogenomics. 2016 Oct 28. [Epub ahead of print] F.I.: 2.701
[Neonatal intestinal obstruction due to cecal duplication]. Cir Pediatr. 2016 Oct 10;28(4):205-207. F.I.
Lercanidipine valuable effect on urine protein losses: the RED LEVEL study. Curr Med Res Opin. 2016 Oct;32(sup2):29-34. F.I.: 2.643
External validation of the A2SD2 and ISAN scales for predicting infectious respiratory complications of ischaemic stroke.Neurologia. 2016 Oct 21. pii: S0213-4853(16)30208-0. F.I.: 1.790